Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe

Allogeneic hematopoietic stem cell transplantation (HSCT) is, to date, the only curative treatment for sickle cell disease (SCD). Because an human leukocyte antigen (HLA)-matched sibling donor is not always available, alternative stem cell sources such as unrelated or haploidentical related donors h...

Description complète

Détails bibliographiques

Auteurs principaux:	Eliane Gluckman, Barbara Cappelli, Graziana Maria Scigliuolo, Josu De la Fuente, Selim Corbacioglu
Format:	Artigo
Langue:	Inglês
Publié:	Wolters Kluwer Medknow Publications 2020-10-01
Collection:	Hematology/Oncology and Stem Cell Therapy
Sujets:	alternative donor hsct haploidentical hsct sickle cell disease unrelated donor hsct
Accès en ligne:	https://journals.lww.com/10.1016/j.hemonc.2019.12.011
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!